FDA Seizure Of GSK Products Exemplifies Heightened Warning Letter Gravitas
This article was originally published in The Tan Sheet
Executive Summary
The seizure of two of GlaxoSmithKline's major prescription drugs is an example of the increased seriousness FDA is placing on individual warning letters
You may also be interested in...
GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns
GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns
GSK Consent Decree Sets “Aggressive” 150-Day Timeline For GMP Conformity
GlaxoSmithKline's consent decree mandates that the company notify the agency within 150 days of the corrective measures it has taken or plans to take in addressing FDA's good manufacturing practice concerns